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Abstract
Vascular stiffness has been proposed as a
simple method to assess arterial loading con-
ditions of the heart which induce left ventric-
ular hypertrophy (LVH). There is some contro-
versy as to whether the relationship of vascu-
lar stiffness to LVH is independent of blood
pressure, and which measurement of arterial
stiffness,  augmentation  index  (AI)  or  pulse
wave  velocity  (PWV)  is  best.  Carotid  pulse
wave  contor  and  pulse  wave  velocity  of
patients  (n=20)  with  hypertension  whose
blood  pressure  (BP)  was  under  control
(<140/90 mmHg) with antihypertensive drug
treatment medications, and without valvular
heart disease, were measured. Left ventricular
mass,  calculated  from  2D  echocardiogram,
was adjusted for body size using two different
methods: body surface area and height. There
was a significant (P<0.05) linear correlation
between LV mass index and pulse wave veloc-
ity. This was not explained by BP level or lower
LV mass in women, as there was no significant
difference  in  PWV  according  to  gender
(1140.1+67.8  vs 1110.6+57.7  cm/s).  In  con-
trast to PWV, there was no significant correla-
tion  between  LV  mass  and  AI.  In  summary,
these data suggest that aortic vascular stiff-
ness is an indicator of LV mass even when
blood pressure is controlled to less than 140/90
mmHg in hypertensive patients. The data fur-
ther suggest that PWV is a better proxy or sur-
rogate marker for LV mass than AI and the
measurement of PWV may be useful as a rapid
and  less  expensive  assessment  of  the  pres-
ence of LVH in this patient population.
Introduction
Increased  left  ventricular  mass  (LVH)  in
patients with hypertension is a significant pre-
dictor of subsequent morbidity and mortality.1,2
The mechanisms by which hypertension pro-
duces  LVH  are  complex  but  are  believed  to
involve an increased (after)load on the heart
along  with  neurohumeral  factors  found  in
hypertension, to initiate a signal transduction
cascade  leading  to  myocardial  cell  hypertro-
phy.3,4 The load on the left ventricle is a com-
posite of load inertia (overcoming the inertia
and viscous elements of the blood), dynamic
loading (aortic arterial pressure), and resist-
ance loading (the properties of the aorta into
which  the  ventricle  is  ejecting  blood).5 The
aortic component of the resistance load can be
considered as aortic compliance, which in turn
is a function of the physical properties of the
artery  (viscoelasticity,  dimensions,  etc.)  and
the reflected pressure waves generated in the
more distal parts of the arterial tree.6 While
arterial viscoelasticity and reflected waves are
inter-related properties of the large arteries,
viscoelastic  properties  may  be  more  readily
measured by pulse wave velocity (PWV), the
speed of travel of the pulse wave in the aorta.
Reflected waves are indicated by augmentation
index  (AI)  or  the  amount  of  increase  or
decrease in the second part of the aortic pulse
contour as a percentage of the peak. 
The  relationship  of  arterial  stiffness  and
left  ventricular  mass  in  individuals  without
kidney disease is controversial. Several stud-
ies  reported  a  significant  relationship
between PWV and LV mass but only if the level
of systolic BP is not considered in the analy-
sis.7-9 Once blood pressure was considered, or
the data were adjusted for the blood pressure
level, no relationship was evident.9 PWV did
not correlate with LV mass in two studies with
untreated  hypertensive  patients.10,11 While
arterial compliance did not correlate with left
ventricular hypertrophy, in some studies, it did
correlate  with  left  ventricular  concentric
remodeling.12 A  relationship  between  PWV
and LV mass was found in patients with con-
centric cardiac hypertrophy but not after cor-
rection for blood pressure in some9 but not
all13 studies.  Differences  in  the  relationship
between PWV and LV mass have been attrib-
uted to gender with a significant relationship
reported in women but not in men. This, how-
ever, has not been consistent.14 A significant
correlation between reflected waves, as meas-
ured by augmentation index, and LV mass has
been reported in normotensive subjects15 and
patients with hypertension.10,16
The  non-linear  pressure-volume  relation-
ship  in  the  vasculature  means  that  arterial
stiffness  is  positively  related  to  distending
pressure.17 The higher the blood pressure at
the time of the measurement, the higher the
measured  arterial  stiffness  without  any
change in the structure of the vessel. Thus
functional as distinct from structural modifi-
cation of arterial stiffness17 may explain the
variable and at times discordant relationship
between  LV  mass  and  reflected  waves  in
patients with hypertension and elevated arte-
rial pressure. One way to overcome this issue
is  to  assess  arterial  stiffness  in  individuals
with hypertension whose blood pressure has
been normalized. We examined the hypothesis
that,  in  patients  with  hypertension  whose
blood pressure had been controlled with anti-
hypertensive  drug  therapy,  arterial  stiffness
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will correlate with left ventricular mass, and
that one of the two indices of arterial stiffness
will be better than the other. 
Materials and Methods
Study subjects
Patients  from  a  cardiology  clinic  at  a
University  teaching  hospital  were  studied.
Inclusion criteria were: men or women, aged
50  to  85  years,  who  had  had  hypertension
requiring antihypertensive drug therapy for at
least one year and whose blood pressure had
been  reduced  to  less  than  140/90mmHg.
Patients were excluded if they had secondary
hypertension and/or had significant renal dis-
ease (eGFR <60 mL/min/1.73 m2).
Study procedures
PWV and augmentation index were measured
on  an  Omron  Colin  VP1000/2000  (Ill,  USA).
Briefly, the subject was examined while resting
in  a  supine  position,  with  electrocardiogram
electrodes placed on both wrists with a micro-
phone for detecting heart sounds placed on the
left edge of the sternum. After the participants
had  rested  in  the  supine  position,  the  right
carotid pulse wave and femoral artery contours
were recorded simultaneously by placement of a
transducer over these arteries. Using the carotid
pressure  waveform,  the  augmentation  index
(AI) was calculated as the difference between
the second and the first systolic shoulder, and
expressed as a percentage of the carotid pulse
contour. PWV was calculated as the ratio of the
distance in meters from the heart to the femoral
artery (based on patient height), to the transit
time in seconds from the heart to the beginning
of the upstroke of the carotid pulse, to the begin-
ning  of  the  upstroke  of  the  arterial  pressure
waveform at the femoral artery, plus an estimate
of  transit  time  from  heart  to  carotid  artery
(onset of S2 to carotid dicrotic notch) (Omron
Colin VP1000/2000 Ill, USA). 
Two-dimensional  echocardiograms  were
performed.  Parasternal  long-  and  short-axis
views were used to determine LV end-diastolic
and end-systolic measurements and wall thick-
ness dimensions according to the recommen-
dations  of  the  American  Society  of
Echocardiography.18 All  measurements  were
recorded by an ultrasonographer who had not
been informed of the patient’s clinical condi-
tion.  Left  ventricular  mass  was  calculated
according to the formula:
1.04 ([LVIDd+IVSTd+PWTd]3–LVIDd3)–14 g
where:  LVIDd  is  the  left  ventricular  internal
dimension at end-diastole; IVSTd is the inter-
ventricular  septal  thickness  at  end-diastole;
PWTd is the posterior wall thickness at end-
diastole. 
Two methods were used to adjust for body
size. LVM was divided by body surface
([(weight0.425¥height0.725)/139.2])
or divided by height.2.7 The latter is considered
a  more  precise  adjustment  of  body  size
because  it  avoids  errors  in  estimating  the
impact of being overweight.19
Statistical analysis
To assess the relationship between two vari-
ables, linear least squares regression analysis
was performed. Comparison of between group
means  used  analysis  of  variance.  The  null
hypothesis  was  rejected  at  the  5%  level
(P<0.05). Sample size calculations were not
performed because there were no prior data on
which to base them.
Results
Patients’ demographics show that the group
had  a  mean  age  of  67.8  years  (range  54-83
years) with 75% being 60 years of age or older.
Sixty percent were men and the group had an
average blood pressure of 129/75 mmHg (Table
1).  Thirty  percent  had  concomitant  diabetes
mellitus. All patients had been suffering from
hypertension for at least two years. All were
receiving antihypertensive drugs with all major
classes of drugs being represented. Fifty-five
percent were taking combinations of more than
one antihypertensive medication. The echocar-
diographic data indicate normal left ventricular
size and systolic function (Table 2). Left ven-
tricular  mass  was  normalized  for  body  size
using two different methods: body surface area
and height to the power of 2.7.
The vascular segment from the heart to the
femoral  artery  (hfPWV)  was  considered  the
major load on the heart and was 1375±61.0
cm/s for the patient group. There was a signif-
icant correlation between hfPWV and LV mass.
The correlation was significant after left ven-
tricular  mass  was  adjusted  for  body  size  by
either body surface area or height2,7 (Figure
1). Because women have lower LV mass than
men, we tried to determine whether the rela-
tionship between PWV and LV mass could be
due to difference in gender, i.e. a lower PWV in
women with lower LV mass and higher PWV in
men with higher LV mass. This was not the
case.  There  was  no  significant  difference
between cfPWV in women and men which was
1140.1±67.8 vs 1110.6±57.7 cm/s, respectively.
In the group of patients whose blood pressure
was  controlled,  there  was  no  relationship
between blood pressure and LV mass as there
was no significant correlation between systolic
blood pressure or mean blood pressure and LV
mass adjusted for body surface area (r2=0.010)
or height2.7 (r2=0.021). 
The  group  had  an  augmentation  index  of
19.0±3.3%. There was no correlation between
augmentation index and left ventricular mass
(Figure 2). Because AI can be related to heart
rate,  we  examined  the  relationship  of  heart
rate  to  LV  mass.  There  was  no  correlation
between heart rate and LV mass adjusted for
body  surface  area  (r2=0.048)  or  height2.7
(r2=0.030).  The  absence  of  a  correlation
between augmentation index and hfPWV indi-
cated  that  these  variables  are  unrelated
(Figure 3). 
Discussion
This  study  examined  a  unique  group  of
hypertensive  patients  whose  blood  pressure
had been reduced to less than 140/90 mmHg by
antihypertensive  drug  therapy,  and  found  a
Table 2. Echocardiographic data.
Echocardiographic data Mean±SD
LVDD (mm) 45.4±4.6
LVSD (mm) 29.6±4.8
IVS (mm) 10.4±1.3
PW (mm) 10.2±1.0
LA size (mm) 40.2±6.3
LA volume (ml) 39.3±3.6
LV mass (male) (g) 160.4±25.1
LV mass index (male) (g/m2) 80.8±13.6 
LV mass index (male) (g/Ht2.7) 36.0±6.9 
LV mass (female) (g) 122.9±11.5
LV mass index (female) (g/m2) 73.5±11.7
LV mass index (female) (g/ Ht2.7) 33.7±4.7
Ejection fraction (%) 60.9±6.7
Table 1. Patients’ clinical characteristics.
Characteristics Total
N. patients 20
Age (years) 67.8±9.3*
Male (%) 60
Systolic blood pressure (mmHg) 129.0±7.2
Diastolic blood pressure (mmHg) 75.4±9.8
Heart rate (bpm) 65.4±10.4
BMI (Kg/m2) 24.9.1±3.9
Type 2 diabetes mellitus (%) 30.0%
Antihypertensive medications°
CCB 30%
ACEi/ARB 75%
Beta blocker 40%
Diuretic 55%
*Mean+SD; °55% of patients were on 2 or more medications from
different classes.Article
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significant relationship between LV mass and
PWV. In contrast, there was no significant rela-
tionship between AI index and LV mass. These
data suggest that PWV detects vascular abnor-
malities  that  are  not  recognized  by  AI,  and
PWV  correlates  better  with  a  target  organ
effect of hypertension, even once blood pres-
sure has fallen to within a normal or accept-
able target range after treatment. 
A complex interplay between aortic PWV and
left ventricle hypertrophy in hypertensive sub-
jects has been proposed by Schillaci et al. They
found that, in middle-aged and older subjects,
PWV is overwhelmingly determined by aortic
stiffness,  while  in  young  individuals  (<40
years of age) aortic PWV is determined to a
significant extent by the velocity of LV contrac-
tion.11 As  our  patient  group  was  mainly  54
years of age or over, PWV was determined by
aortic stiffness and not the velocity of LV con-
traction. We did not adjust for age, because we
used left ventricular mass rather than LV wall
thickness. In healthy adults, relative wall thick-
ness increases with age whereas left ventricu-
lar mass does not change.20The relationship of
PWV to LV mass has been suggested to vary in
men and women14 but we found no gender dif-
ferences in LV mass. 
We found a significant relationship between
PWV and LV mass. Most of the studies that did
not show a correlation between PWV and LV
mass  studied  either  untreated  hypertensive
patients10,11 or non-hypertensive individuals.12
In addition to differences in the patient popula-
tion, our study used the heart to femoral vascu-
lar  segment  to  assess  PWV  rather  than  the
shorter carotid to femoral PWV used by others.
The longer segment, which includes the proxi-
mal aorta, should be more representative of the
load  on  the  left  ventricle.  Also,  the  heart  to
femoral segment is a more powerful indicator
of arterial disease than other arterial segments. 
Blood  pressure  (systolic  or  diastolic)  was
not a factor in the present study as hyperten-
sion had been controlled, and there was no cor-
relation between blood pressure and LV mass. 
The  relationship  of  PWV  to  LV  mass  has
been  reported  to  disappear  after  adjustment
for elevated blood pressure.7-9 This has led to
conflicting  suggestions  that  blood  pressure
load on the ventricle, regardless of the cause,
is the most important factor producing LVH, or
that decreases in aortic compliance/distensi-
bility  produce  cardiac  hypertrophy  mainly
through  the  increase  in  systolic  pressure.9
Whether this increase in aortic stiffness is the
cause or effect of the elevated systolic blood
pressure,  however,  remains  unresolved.21 In
contrast, our study suggests that the relation-
ship of PWV to LV mass was independent of
blood pressure. 
There was no relationship between AI and
LV mass in this patient group, in contrast to
Hashimoto et al.10 However, they reported on
untreated hypertensive patients and assessed
carotid femoral PWV and this may account for
the differences between the two studies. The
very small r value makes it highly unlikely that
a relationship would have been seen with a
much larger study group. The significant rela-
tionship between PWV but not AI and LV mass
may have several explanations. The main rea-
son could be that the vasculature component,
related to arterial stiffness whose link to LV
mass is stronger and lasts longer,6is measured
by PWV and not AI. Our study is consistent with
the concept that PWV and AI measure different
components of the vasculature. Aortic compli-
ance is a function of the physical properties of
the  artery  (viscoelasticity,  dimensions,  etc.)
and the reflected pressure waves generated in
the more distal parts of the arterial tree.6 The
hypothesis that PWV reflects the viscoelastic
properties of the aorta and AI is an indicator of
the reflected waves seems to be a reasonable
way  to  differentiate  between  PWV  and  AI.
These two factors are interrelated as increased
arterial stiffness can be measured by both PWV
and AI. However, our data have shown differ-
ences in relationship to a target organ effect of
hypertension. PWV, but not AI, has been found
to be associated with diabetic retinopathy in
patients  with  diabetes.22 Another  possibility
expressed  by  some  investigators  is  that
increased  AI  is  not  a  reliable  surrogate  for
increased aortic stiffness.23 Regardless of this,
our study found differences between PWV and
AI with respect to linking the vasculature to
the process of LVH.
Consistent with the different relationships
between LV mass and PWV compared to AI, we
did not find any correlation between PWV and
AI in this patient population. The absence of a
correlation between PWV and AI is supported
by  the  work  of  others.24 The  differences
between PWV and AI can be due not only to
measurement  of  different  properties  of  the
vasculature but other differences reflect that
AI is also more influenced than PWV by heart
rate and blood pressure.25,26 Another potential
explanation for our finding is that antihyper-
tensive  drugs  may  more  readily  reverse  the
reflected  wave  component  of  arterial  resist-
ance  than  hypertension-induced  changes  in
the  viscoelastic  properties  of  the  aorta.  The
majority  of  the  patients  in  this  study  were
receiving  angiotensin  converting-enzyme
inhibitors (ACEs), angiotensin receptor block-
ers or calcium channel blockers. These agents
have been shown to reduce AI.27-30 The next
most common agent, diuretics, appears not to
change AI, while beta blockers may increase
AI.31,32 The  patients  in  our  study  also  used
combination  drug  therapy  that  would  be
expected to reduce AI.33 Peripheral muscular
arteries,  from  which  reflected  waves  arise,
Figure  1. The  relationship  of  pulse  wave
velocity: heart to femoral (hfPWV) to left
ventricular mass adjusted for height (upper
panel) or body surface area (lower panel).
Figure 2. The relationship of augmentation
index to left ventricular mass adjusted for
height (upper panel) or body surface area
(lower panel).
Figure 3. The relationship of augmentation
index to pulse wave velocity (hfPWV)Article
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may  be  more  amenable  to  antihypertensive
drugs than central arterial stiffness. This latter
proposal would be consistent with those inves-
tigators who believe that LVH is mediated pri-
marily  through  increases  in  blood  pressure
and that there should be no LVH once blood
pressure is normalized. While our study might
raise the question as to how increased PWV
could lead to LVH in the absence of a relation-
ship  between  blood  pressure  and  LVH,  it  is
more likely that our results are consistent with
the concept that differences in vascular stiff-
ness and LVH can still be observed in patients
whose blood pressure is lowered or even nor-
malized with antihypertensive drugs. 
This  study  has  several  limitations  which
need to be considered: i) the small sample size
is of concern. However, a statistically signifi-
cant relationship between PWV and LVH was
identified even with this small number of par-
ticipants. Furthermore, the correlation coeffi-
cient between AI and LVH was extremely small
so that it would have been unlikely that even a
much larger sample size would have shown a
significant  relationship;  ii)  PWV  is  usually
measured between two points; the use of heart
to femoral PWV partially relied on the use of a
heart sound as a reference point for PWV that
may  have  influenced  the  findings.  However,
measurement  of  the  segment  from  heart  to
carotid upstroke usually relies on this as an
indicator of onset of left ventricular ejection;
iii) there may have been an underlying rela-
tionship between heart rate and/or blood pres-
sure and PWV or AI that was not taken into
account in the univariate analysis relating PWV
or AI to LVH. While this possibility cannot be
excluded, there was no statistically significant
relationship between LVH and either heart rate
or blood pressure suggesting that it is unlikely
that the association of PWV with LVH was medi-
ated through blood pressure or heart rate; iv) AI
was lower than anticipated in this study group
of whom the majority were older than 60 years;
v) there might be a concern that it is difficult to
differentiate  the  (true)  relationship  between
LVH and PWV or AI, from different effects of
antihypertensive drugs on AI or PWV in this
study. However, it is not possible to obtain a
patient group with hypertension that is signifi-
cant  enough  to  induce  cardiovascular  alter-
ations  and  have  blood  pressure  normalized
unless  antihypertensive  drugs  are  used.
Specific drug effects are an unlikely explana-
tion for the findings of the study because the
majority of patients were being treated by the
same class of agents, i.e. rennin angiotensin
system inhibitors. We did not include a nor-
motensive group to compare with the controlled
hypertension group in order to eliminate drug
effect because the normotensive group would
be  expected  to  show  a  relationship  between
vascular stiffness and LV mass. 
In summary, PWV but not AI correlates sig-
nificantly with LV mass in hypertensive indi-
viduals  whose  blood  pressures  have  been
reduced to less than 140/90 mmHg. These find-
ings  suggest  that  the  component  of  arterial
compliance measured by PWV is a more impor-
tant determinant of LV mass or that antihyper-
tensive drugs can not as readily correct the
changes in the vasculature that alter PWV as
they  can  reduce  the  increase  in  reflected
waves that generate AI. The data further sug-
gest that PWV is a better proxy or surrogate
marker for LV mass than AI and the measure-
ment of PWV may be useful as a rapid and less
expensive assessment of the presence of LVH
in this patient population.
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